When I look back on 2025, what stands out most is not the size of the regulatory wave we all rode — but the fact that our ...

Semaglutide initiation is associated with a lower risk for adult-onset epilepsy or seizures in patients with T2DM, according ...

Incretin-based obesity medications may result in higher muscle-related loss vs. other weight loss strategies, according to ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...

Moderate to severe glabellar lines may be effectively and safely treated with YY001, a new recombinant botulinum toxin type A product.

Ultimate disposition showed 54% approval (7% same-day; 47% after multiple days) and 46% denial, with 27% rejected within 1 ...

Introduction Mindfulness-based interventions are widely used, yet concerns about potential negative effects—particularly those related to mindfulness meditation practice—have gained increasing ...

The hardware and software changes should perk up decision makers at border agencies, forensic laboratories and central banks.

Selpercatinib is approved for several therapeutic indications, including as monotherapy for the treatment of advanced RET-mutant medullary thyroid cancer in the first line. The drug blocks an enzyme ...

Objective The multinational ERYTHRO ( NCT06046534) study investigated the experience of patients with moderate-to-severe SLE ...

Discover how a 1031 exchange works to defer capital gains taxes on real estate. Learn the rules, timelines, and strategies to ...

SGLT2 inhibitors may reduce gout flares and decrease the need for urate-lowering and acute gout medications in adults with ...